{
    "success": true,
    "data": {
        "ucits": true,
        "type": "ETF",
        "replication_method": "synthetic",
        "derivatives": true,
        "swaps": true,
        "inverse": false,
        "leverage": false,
        "complex_factors": [
            "FX forward contracts",
            "Rolling of forward contracts",
            "Counterparty risk",
            "Collateral risk",
            "Limited investor knowledge required"
        ],
        "classification": "complex",
        "supporting_data": "The WisdomTree Short JPY Long USD is classified as an ETF. It is designed to provide exposure to JPY relative to USD by tracking the MSFXSM Short Japanese Yen Total Return Index, which involves the daily performance of FX forward contracts. The product description explicitly states it uses 'FX forward contracts' and mentions the effect of 'rolling' these contracts. The use of derivatives, specifically FX forward contracts, to achieve its investment objective means it relies on instruments that are considered complex under MiFID II due to the inherent risks like counterparty risk and the need for understanding these mechanisms, which are beyond basic financial literacy. While the KID categorizes its risk as 'medium-low' (3 out of 7), the underlying methodology involves derivatives for replication, which is a key determinant of complexity in MiFID II. The product also states it's 'fully collateralised' but this does not negate the complexity introduced by the derivative usage itself. The product targets investors with 'specific knowledge or experience of investing in similar products and in financial markets', reinforcing the idea that it's not intended for basic retail investors without such understanding. ESMA guidelines and MiFID II regulations consistently classify instruments that use derivatives for replication as complex due to the opacity and risks involved (e.g., counterparty risk). The structure of the product, using FX forward contracts to achieve its objective, falls under the 'synthetic replication' category which is generally considered complex. Even though it is a UCITS eligible product, the use of derivatives for its core strategy leads to a complex classification. Therefore, despite a potentially medium-low risk rating, the inherent complexity of the replication strategy makes it a complex financial instrument under MiFID II."
    }
}